Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Bio Planet's Debt-to-EBITDA or its related term are showing as below:
FRA:8WS'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.48 Med: 3.39 Max: 8.84
Current: 2.72
During the past 13 years, the highest Debt-to-EBITDA Ratio of Bio Planet was 8.84. The lowest was 1.48. And the median was 3.39.
FRA:8WS's Debt-to-EBITDA is ranked worse than 58.41% of 1551
companies
in the Consumer Packaged Goods industry
Industry Median: 2.08
vs FRA:8WS: 2.72
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Bio Planet Debt-to-EBITDA Related Terms
Bio Planet Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Bio Planet's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Bio Planet's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio Planet Debt-to-EBITDA vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Bio Planet's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Bio Planet's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Bio Planet (FRA:8WS) has a Debt-to-EBITDA of 0.00 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Bio Planet. Over the past decade, Bio Planet's Debt-to-EBITDA has ranged from 1.48 to 8.84. According to the industry distribution chart, Bio Planet ranks #906 out of 1551 companies in the Consumer Packaged Goods industry, placing it in the top 58.4%.
Is Bio Planet's Debt-to-EBITDA too high?
Bio Planet's current Debt-to-EBITDA is 0.00. Over the past 10 years, this metric has ranged from a low of 1.48 to a high of 8.84. Based on the distribution chart, Bio Planet ranks #906 out of 1551 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Bio Planet has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Bio Planet's Debt-to-EBITDA compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Bio Planet ranks #906 out of 1551 companies for Debt-to-EBITDA. This places Bio Planet in the lower half of its industry. The industry median Debt-to-EBITDA is 2.08. Historically, Bio Planet's own Debt-to-EBITDA has ranged from 1.48 to 8.84 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Consumer Packaged Goods company?
The median Debt-to-EBITDA among Consumer Packaged Goods companies is 2.08, based on 1,551 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Bio Planet. For the Consumer Packaged Goods industry, the median Debt-to-EBITDA is 2.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bio Planet's current Debt-to-EBITDA is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Planet stock overvalued right now?
Bio Planet (FRA:8WS) has a current Debt-to-EBITDA of 0.00. The stock's GF Value™ is €4.87, compared to a current price of €6.72 — trading 38% above its estimated fair value. The current Debt-to-EBITDA is 0.00. Bio Planet's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Bio Planet (FRA:8WS), the current Debt-to-EBITDA is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bio Planet (FRA:8WS) Overvalued in 2026?
Based on GuruFocus' analysis, Bio Planet stock appears to be overvalued.
The current stock price of €6.72 is trading 38% above its estimated GF Value™ of €4.87.
Key valuation signals for FRA:8WS:
Debt-to-EBITDA: 0.00
GF Value™: €4.87 vs. price of €6.72 (38% above fair value)
No single metric tells the full story. See the FRA:8WS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bio Planet SA is a producer and distributor of organic food under its own brand Bio Planet. It also develops the department of organic foodservice packaging (private label). The product offerings of the company include Marmalades, Proteins, Sauces, Legumes, Vegetables, Sausages and Spices and Herbs among others.
76GF Score
Get the complete analysis for FRA:8WS
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:8WS has been successfully added to your 
